Q2 2025 · 13F-HR
DAFNA Capital Management LLCholdings as filed
Filed 2025-08-14 · accession 0001389932-25-000011
$362.3M
Reported value
76
Positions
2025-06-30
Period end
The Brief · DAFNA Capital Management LLC · Q2 2025
AI · grounded in 13F
DAFNA Capital Management LLC established a new position in the SPDR S&P BIOTECH ETF XBI valued at $34.46M. The fund also initiated new stakes in STEREOTAXIS INC STXS for $29M and REVOLUTION MEDICINES INC RVMD for $24.91M. Additional new positions include BLUEPRINT MEDICINES CORP 2655787D and MERUS BV 2GH.
Holdings as filed
| CUSIP | Ticker | Issuer | Value | % port. | Shares | Class | Voting |
|---|---|---|---|---|---|---|---|
| 78464A870 | XBI | SPDR S&P BIOTECH ETF | $34.5M | 9.51% | 415,505 | Common | SOLE |
| 85916J409 | STXS | STEREOTAXIS INC | $29.0M | 8.01% | 13,680,554 | Common | SOLE |
| 76155X100 | RVMD | REVOLUTION MEDICINES INC | $24.9M | 6.88% | 677,176 | Common | SOLE |
| 09627Y109 | 2655787D | BLUEPRINT MEDICINES CORP | $21.6M | 5.97% | 168,763 | Common | SOLE |
| N5749R100 | 2GH | MERUS BV | $21.0M | 5.79% | 398,804 | Common | SOLE |
| 04963C209 | ATRC | ATRICURE INC | $19.4M | 5.36% | 592,273 | Common | SOLE |
| 23282W605 | CYTK | CYTOKINETICS INC | $13.2M | 3.63% | 398,100 | Common | SOLE |
| 45166A102 | IDYA | IDEAYA BIOSCIENCES INC | $13.0M | 3.59% | 619,090 | Common | SOLE |
| 464287556 | IBB | ISHARES NASDAQ BIOTECH INDX | $13.0M | 3.58% | 102,500 | Common | SOLE |
| 04351P101 | ASNDUSD | ASCENDIS PHARMA A/S | $12.5M | 3.46% | 72,677 | Common | SOLE |
| 98420N105 | XENE | XENON PHARMACEUTICALS INC | $9.0M | 2.49% | 287,939 | Common | SOLE |
| 64125C109 | NBIX | NEUROCRINE BIOSCIENCES INC | $8.9M | 2.45% | 70,615 | Common | SOLE |
| 05463X106 | AXGN | AXOGEN INC | $8.0M | 2.22% | 741,782 | Common | SOLE |
| 483497103 | KALV | KALVISTA PHARMACEUTICALS INC | $6.6M | 1.82% | 581,757 | Common | SOLE |
| 252131107 | DXCM | DEXCOM INC | $5.7M | 1.58% | 65,552 | Common | SOLE |
| 23954D109 | DAWNGBX | DAY ONE BIOPHARMACEUTICALS I | $5.7M | 1.58% | 879,163 | Common | SOLE |
| 86150R107 | STOK | STOKE THERAPEUTICS INC | $5.7M | 1.57% | 501,972 | Common | SOLE |
| 875372203 | TNDM | TANDEM DIABETES CARE INC | $5.5M | 1.51% | 294,208 | Common | SOLE |
| 03969F109 | RCUS | ARCUS BIOSCIENCES INC | $5.1M | 1.41% | 627,626 | Common | SOLE |
| 87164F105 | SNDX | SYNDAX PHARMACEUTICALS INC | $5.1M | 1.41% | 543,602 | Common | SOLE |
| 603170101 | MLYS | MINERALYS THERAPEUTICS INC | $5.0M | 1.39% | 371,523 | Common | SOLE |
| 04351PAD3 | ASND 2.25 04/01/28 | ASCENDIS PHARMA A/S | $5.0M | 1.38% | 4,000,000 | Common | SOLE |
| M96088105 | URGN | UROGEN PHARMA LTD | $4.8M | 1.32% | 349,515 | Common | SOLE |
| 45780L104 | INGN | INOGEN INC | $4.3M | 1.18% | 605,625 | Common | SOLE |
| 36315X101 | LKFT | GALAPAGOS NV | $3.6M | 1.01% | 130,175 | Common | SOLE |
| G1110E107 | BHVN | BIOHAVEN LTD | $3.3M | 0.92% | 235,235 | Common | SOLE |
| N71542109 | PRQR | PROQR THERAPEUTICS N V | $3.2M | 0.88% | 1,567,561 | Common | SOLE |
| 28036F105 | EWTX | EDGEWISE THERAPEUTICS INC | $3.1M | 0.86% | 238,140 | Common | SOLE |
| 45784P101 | PODD | INSULET CORP | $3.1M | 0.86% | 9,900 | Common | SOLE |
| 45258J102 | IMVT | IMMUNOVANT INC | $3.1M | 0.85% | 191,493 | Common | SOLE |
| G01767105 | ALKS | ALKERMES PLC | $3.0M | 0.82% | 103,748 | Common | SOLE |
| 055477103 | BCAX | BICARA THERAPEUTICS INC | $2.9M | 0.81% | 317,001 | Common | SOLE |
| 872381108 | TELA | TELA BIO INC | $2.8M | 0.77% | 1,441,029 | Common | SOLE |
| 50127T109 | KURA | KURA ONCOLOGY INC | $2.7M | 0.74% | 463,368 | Common | SOLE |
| 24823R105 | DNLI | DENALI THERAPEUTICS INC | $2.4M | 0.65% | 168,500 | Common | SOLE |
| 20451W101 | CMPS | COMPASS PATHWAYS PLC | $2.3M | 0.63% | 811,046 | Common | SOLE |
| 016255101 | ALGN | ALIGN TECHNOLOGY INC | $2.1M | 0.57% | 11,000 | Common | SOLE |
| 09058V103 | BCRX | BIOCRYST PHARMACEUTICALS INC | $2.0M | 0.54% | 218,255 | Common | SOLE |
| 04635X102 | CATBUSD | ASTRIA THERAPEUTICS INC | $1.7M | 0.48% | 324,775 | Common | SOLE |
| 492327101 | KROS | KEROS THERAPEUTICS INC | $1.7M | 0.48% | 130,316 | Common | SOLE |
| 92686J106 | VKTX | VIKING THERAPEUTICS INC | $1.7M | 0.47% | 64,516 | Common | SOLE |
| 004397105 | ARAY | ACCURAY INC | $1.7M | 0.46% | 1,222,358 | Common | SOLE |
| 10501L106 | BWAY | BRAINSWAY LTD | $1.7M | 0.46% | 127,151 | Common | SOLE |
| 019770106 | ALLO | ALLOGENE THERAPEUTICS INC | $1.6M | 0.43% | 1,380,118 | Common | SOLE |
| 52886X107 | LXEO | LEXEO THERAPEUTICS INC | $1.5M | 0.42% | 378,083 | Common | SOLE |
| 344174107 | FHTX | FOGHORN THERAPEUTICS INC | $1.4M | 0.39% | 300,452 | Common | SOLE |
| 46565G104 | 5E7 | ITEOS THERAPEUTICS INC | $1.4M | 0.39% | 140,847 | Common | SOLE |
| 68622P109 | ORIC | ORIC PHARMACEUTICALS INC | $1.4M | 0.38% | 135,271 | Common | SOLE |
| 20454B104 | CMPX | COMPASS THERAPEUTICS INC | $1.4M | 0.38% | 526,660 | Common | SOLE |
| N44445109 | IMTX | IMMATICS NV | $1.3M | 0.36% | 245,000 | Common | SOLE |
| 014442107 | ALEC | ALECTOR INC | $1.3M | 0.35% | 912,928 | Common | SOLE |
| M68830112 | MDWD | MEDIWOUND LTD | $1.2M | 0.34% | 64,479 | Common | SOLE |
| 86366E106 | GPCR | STRUCTURE THERAPEUTICS INC | $1.2M | 0.34% | 59,000 | Common | SOLE |
| 09203E105 | BDTX | BLACK DIAMOND THERAPEUTICS I | $1.2M | 0.32% | 471,000 | Common | SOLE |
| 517125100 | LRMR | LARIMAR THERAPEUTICS INC | $1.1M | 0.30% | 371,434 | Common | SOLE |
| 92941V308 | VYNE | VYNE THERAPEUTICS INC | $1.0M | 0.29% | 636,103 | Common | SOLE |
| 38341P102 | GOSS | GOSSAMER BIO INC | $1.0M | 0.29% | 849,921 | Common | SOLE |
| 697947109 | PVLA | PALVELLA THERAPEUTICS INC | $977,064 | 0.27% | 43,348 | Common | SOLE |
| 05280R100 | AUTL | AUTOLUS THERAPEUTICS PLC | $970,404 | 0.27% | 425,616 | Common | SOLE |
| 15673T100 | IPSC | CENTURY THERAPEUTICS INC | $952,154 | 0.26% | 1,704,232 | Common | SOLE |
| 64135M105 | NGNE | NEUROGENE INC | $763,885 | 0.21% | 51,096 | Common | SOLE |
| 09075V102 | BNTX | BIONTECH SE | $745,290 | 0.21% | 7,000 | Common | SOLE |
| M8001Q126 | PYPD | POLYPID LTD | $733,887 | 0.20% | 207,900 | Common | SOLE |
| 500946108 | KRRO | KORRO BIO INC | $720,561 | 0.20% | 57,691 | Common | SOLE |
| M25722105 | CGEN | COMPUGEN LTD | $484,876 | 0.13% | 272,402 | Common | SOLE |
| 03843E104 | AQST | AQUESTIVE THERAPEUTICS INC | $470,020 | 0.13% | 142,000 | Common | SOLE |
| 088786108 | BCYC | BICYCLE THERAPEUTICS PLC | $448,219 | 0.12% | 64,492 | Common | SOLE |
| 29479A108 | ERAS | ERASCA INC | $444,500 | 0.12% | 350,000 | Common | SOLE |
| 007002108 | TORCEUR | ADICET BIO INC | $329,400 | 0.09% | 540,000 | Common | SOLE |
| H0036K147 | ADCT | ADC THERAPEUTICS SA | $327,177 | 0.09% | 122,081 | Common | SOLE |
| 869367102 | STRO | SUTRO BIOPHARMA INC | $312,031 | 0.09% | 437,079 | Common | SOLE |
| 640268306 | NKTR | NEKTAR THERAPEUTICS | $258,400 | 0.07% | 10,000 | Common | SOLE |
| 03836J201 | APRE | APREA THERAPEUTICS INC | $231,824 | 0.06% | 137,174 | Common | SOLE |
| 09090D301 | PHGE | BIOMX INC | $180,511 | 0.05% | 401,136 | Common | SOLE |
| 74276L105 | PRCT | PROCEPT BIOROBOTICS CORP | $172,800 | 0.05% | 3,000 | Common | SOLE |
| N44821101 | IFRX | INFLARX NV | $158,000 | 0.04% | 200,000 | Common | SOLE |
Source: SEC EDGAR · raw 13F holdings as filed. The Class column shows the option type when reported (Put/Call) or Common when the issuer's equity is held directly. 13F discloses long positions only.